Clinflamozyde

N/A

Report date: 2024/04/11 14:04:16
NME

Base Information

Drug NameClinflamozyde
Drug Alias NameGEA-001
ClassificationSmall molecules
Mechanisms of ActionSignal transducer and activator of transcription 5A inhibitorsSignal transducer and activator of transcription 5B inhibitors
TargetsSignal transducer and activator of transcription 5ASignal transducer and activator of transcription 5B
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesGenEros Biopharma Hangzhou Ltd
China Registration ClassN/A

Develop Information

Active CompaniesGenEros Biopharma Hangzhou Ltd
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A